echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Wang Yiguang's team has made progress in tumor nanovaccine research

    Wang Yiguang's team has made progress in tumor nanovaccine research

    • Last Update: 2022-04-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the academic journal Nano Letters published online the latest research results of Wang Yiguang's research team from the State Key Laboratory of Natural and Biomimetic Medicine, School of Pharmacy, Peking University, "A pH-/enzyme-responsive nanoparticle selectively targets endosomal Toll-like receptors to potentiate robust cancer vaccination.


    In the treatment of malignant tumors, immunotherapy represented by immune checkpoint inhibitors, tumor vaccines, etc.


    Wang Yiguang's research team designed a smart tumor nanovaccine ( TLR activating nanovaccine, TNV ) based on Toll -like receptor agonism based on the existing pH -sensitive ( Ultra-pH-sensitive, UPS ) nanotechnology platform of the research group.


    In the nanovaccine TNV , the TLR7/8 agonist IMDQ was covalently bound to the hydrophobic block of the UPS polymer through an enzyme-sensitive bond GFLG , and formed nanomicelles through cooperative self-assembly .


    Researcher Wang Yiguang of Peking University School of Pharmacy is the corresponding author of this research paper


    From left: Qin Mengmeng, Wang Yiguang, Xia Heming

    Original link: https://pubs.


    About the Author:


    Wang Yiguang, Ph.



    (School of Pharmacy, Peking University)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.